Our Research

Our single objective: to prevent and reverse disability for everyone with multiple sclerosis, neuromyelitis optica and MOG associated disease.

We are using big data and cutting-edge artificial intelligence to identify the right drug, for the right person at the right time.

We are conducting groundbreaking research in the field of remyelination, dedicated to repairing the nervous system.

We are elucidating the relationship between biological ageing, neurological repair and neuronal loss to identify novel treatment pathways.

Explore and learn more about other topics in this section by clicking the headings below: